LPBI Group would like to thank all our readers who have helped our Journal to Hit the 1 Million Viewer Mark!

Newtown, MA -- (SBWIRE) -- 06/20/2016 -- Leaders in Pharmaceutical Business Intelligence (LBPI Group), launched in April 2012 as an Open Access Online Scientific Journal (http://pharmaceuticalintelligence.com), has reached over 1 million unique site visits, with approximately 30,000 monthly views, +2,115 followers, and 300 sites linking into the journal, including ncbi.nlm.nih.gov, Nature.com, commons.wikipedia.org, dx.doi.org, NEJM, personalizedmedicine.partners.org, cancer.gov, medscape.com, masspec.scripps.edu, and sciencedirect.com.

Leaders in Pharmaceutical Business Intelligence Group is a scientific, medical and business multi-expert authoring platform in several domains: life sciences, pharmaceutical, healthcare & medical industries. The venture operates as an online scientific intellectual exchange at its website http://pharmaceuticalintelligence.com for curation and reporting on innovations in biomedical and biological sciences, healthcare economics, pharmacology, pharmaceutical research & medicine. The Open Access Online Scientific Journal currently contains 4,716 annotated & curated articles in over +480 categories of research in Biotech, Life Sciences and Medicine.

About The LBPI Group 3D Printing ADD R&D
The LBPI Group venture publishes a BioMedical Series of e-Books available on mobile platforms (current & future titles at http://pharmaceuticalintelligence.com/biomed-e-books). It also represents a dozen Biotechnology and Medical Devices startups in Private Equity Funding and an IP Development Group, DrugDiscovery@LPBI Group, and Medical 3D Printing.

The venture's expertise in Real-Time Scientific Conferences Coverage, using social media and creating electronic conference proceedings posted on the Internet, has included the following events as well as others: Harvard's 10th, 11th, 12th Personalized Medicine Conferences in 2015 & 2016, CHI Discovery On Target 2016, MassBio 2015 & 2016, MassBioAnnual Meeting 2014, BioIT World, April 30, 2014, Koch Institute for Integrative Cancer Research @MIT – Summer Symposium 2014: RNA Biology, Cancer and Therapeutic Implications, June 13, 2014, Gabbay Award Lectures in Biotechnology and Medicine – Hosted by Rosenstiel Basic Medical Sciences Research Center, Brandeis University, October 27, 2014, 10th Annual Personalized Medicine Conference at the Harvard Medical School, November 12-13, 2014, and two Biotech Investment Conferences in 2014, one in NYC and one in Basel by Sachs Associates of London.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series B: Genomics Orientations for Individualized Medicine, Vol. I is available for Amazon Kindle

Newtown, MA -- (SBWIRE) -- 01/19/2016 -- Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series B:
Genomics Orientations for Individualized Medicine, Vol. I

which is now available on Amazon Kindle at http://www.amazon.com/dp/B018DHBUO6. This e-Book is a comprehensive review of recent Original Research on Genomics and Individualized Medicine and related opportunities for Targeted Therapy written by Experts, Authors, Writers. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation.
Genomics Orientations for Individualized Medicine, Vol. I contains 21 chapters and is divided into 6 main parts including:

I. Classical Model of the Gene
II. Emergence of the Genomic Network
III. Genomics Enters the Clinic
IV. Targeting Cancer
V. Systemic and Organ System Genomics
VI. Advances in Gene Editing Technology with interviews with pioneer of the CRISPR/Cas9 Gene Editing System Jennifer Doudna, Ph.D.,

The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012. All new articles on this subject, will continue to be incorporated, as published with periodical updates.

We invite e-Readers to write an Article Reviews on Amazon for this e-Book on Amazon.

All forthcoming BioMed e-Book Titles can be viewed at:
http://pharmaceuticalintelligence.com/biomed-e-books/

Leaders in Pharmaceutical Business Intelligence, launched in April 2012 an Open Access Online Scientific Journal is a scientific, medical and business multi expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medicine industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceuticals & medicine. In addition the venture publishes a Medical E-book Series available on Amazon's Kindle platform.

Analyzing and sharing the vast and rapidly expanding volume of scientific knowledge has never been so crucial to innovation in the medical field. WE are addressing need of overcoming this scientific information overload by:

> delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search in the near future

> providing a social platform for scientists and clinicians to enter into discussion using social media

> compiling recent discoveries and issues in yearly-updated Medical E-book Series on Amazon's mobile Kindle platform

This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

New ebook on Available on Amazon! Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation

Newtown, MA -- (SBWIRE) -- 01/15/2016 -- Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation which is now available on Amazon Kindle at http://www.amazon.com/dp/B018Q5MCN8.

This e-Book is a comprehensive review of recent Original Research on Cardiovascular Diseases: Causes, Risks and Management and related opportunities for Targeted Therapy written by Experts, Authors, Writers. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012.

Topics covered in greater details include:

- Alternative solutions in Treatment of Heart Failure (HF), medical devices, biomarkers and agent efficacy are handled all in one chapter.

- PCI for valves vs Open heart Valve replacement

- PDA and Complications of Surgery — only curation could create the picture of this unique combination of debate, as exemplified of Endarterectomy (CEA) vs Stenting the Carotid Artery (CAS), ischemic leg, renal artery stenosis. We invite e-Readers to write an Article Reviews on Amazon for this e-Book on Amazon.

All forthcoming BioMed e-Book Titles can be viewed at: http://pharmaceuticalintelligence.com/biomed-e-books/

About Leaders in Pharmaceutical Business Intelligence
Leaders in Pharmaceutical Business Intelligence, launched in April 2012, an Open Access Online Scientific Journal is a scientific, medical and business multi expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medicine industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceuticals & medicine. In addition the venture publishes a Medical E-book Series available on Amazon's Kindle platform.

Analyzing and sharing the vast and rapidly expanding volume of scientific knowledge has never been so crucial to innovation in the medical field. WE are addressing need of overcoming this scientific information overload by:

- Delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search in the near future

- Providing a social platform for scientists and clinicians to enter into discussion using social media

- Compiling recent discoveries and issues in yearly-updated Medical E-book Series on Amazon's mobile Kindle platform

This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Leaders in Pharmaceutical Business Intelligence announces Amazon ebook for Kindle Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine

Newtown, MA -- (SBWIRE) -- 01/15/2016 -- Volume Four: Therapeutic Promise: Cardiovascular Diseases, Regenerative & Translational Medicine which is now available on Amazon Kindle at http://www.amazon.com/dp/B019UM909A.

This e-Book is a comprehensive review of recent Original Research on Cardiovascular Diseases: Causes, Risks and Management and related opportunities for Targeted Therapy written by Experts, Authors and Writers. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012.

Part 1 is concerned with Posttranslational Modification of Proteins, vital for understanding cellular regulation and dysregulation. Part 2 is concerned with Translational Medical Therapeutics, the efficacy of medical and surgical decisions based on bringing the knowledge gained from the laboratory, and from clinical trials into the realm of best practice. The time for this to occur in practice in the past has been through roughly a generation of physicians. That was in part related to the busy workload of physicians, and inability to easily access specialty literature as the volume and complexity increased. This had an effect of making access of a family to a primary care provider through a lifetime less likely than the period post WWII into the 1980s.

We invite e-Readers to write an Article Reviews on Amazon for this e-Book on Amazon.

All forthcoming BioMed e-Book Titles can be viewed at: http://pharmaceuticalintelligence.com/biomed-e-books/

About Leaders in Pharmaceutical Business Intelligence
Leaders in Pharmaceutical Business Intelligence, launched in April 2012 an Open Access Online Scientific Journal is a scientific, medical and business multi expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medicine industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceuticals & medicine. In addition the venture publishes a Medical E-book Series available on Amazon's Kindle platform.

Analyzing and sharing the vast and rapidly expanding volume of scientific knowledge has never been so crucial to innovation in the medical field. WE are addressing need of overcoming this scientific information overload by:

- Delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search in the near future

- Providing a social platform for scientists and clinicians to enter into discussion using social media

- Compiling recent discoveries and issues in yearly-updated Medical E-book Series on Amazon's mobile Kindle platform

This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

LPBI Announces New ebook available on Amazon! Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics

Newtown, MA -- (SBWIRE) -- 01/14/2016 -- Leaders in Pharmaceutical Business Intelligence would like to announce Volume III of their BioMedical E-Book Series E: Patient-Centered Medicine

Volume Three: Milestones in Physiology & Discoveries in Medicine and Genomics which is now available on Amazon Kindle at http://www.amazon.com/dp/B019VH97LU.

This e-Book is a comprehensive review of recent Original Research on Physiology, Medicine, Genomics and related opportunities for Targeted Therapy written by Experts, Authors, Writers. This ebook is mainly about the history of biology, medicine and mankind, but also about how the invention of technology in modern Western society has enabled us to investigate the origins of life, the working of the cell, the classification of species, and the development of medicine and a molecular based emerging pharmaceutical and diagnostics industry which have been separate, and which are merging. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012. All new articles on this subject will continue to be incorporated, as published with periodical updates.

We invite e-Readers to write an Article Reviews on Amazon for this e-Book on Amazon.

All forthcoming BioMed e-Book Titles can be viewed at: http://pharmaceuticalintelligence.com/biomed-e-books/

Leaders in Pharmaceutical Business Intelligence, launched in April 2012 an Open Access Online Scientific Journal is a scientific, medical and business multi expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medicine industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceuticals & medicine. In addition the venture publishes a Medical E-book Series available on Amazon's Kindle platform.

Analyzing and sharing the vast and rapidly expanding volume of scientific knowledge has never been so crucial to innovation in the medical field. WE are addressing need of overcoming this scientific information overload by:

- delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search in the near future

- providing a social platform for scientists and clinicians to enter into discussion using social media

- compiling recent discoveries and issues in yearly-updated Medical E-book Series on Amazon's mobile Kindle platform

This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

LPBI Announces New ebook available now on Amazon! Volume Three: Etiologies of Cardiovascular Diseases – Epigenetics, Genetics and Genomics

Newtown, MA -- (SBWIRE) -- 01/14/2016 -- Leaders in Pharmaceutical Business Intelligence would like to announce the Third volume of their BioMedical E-Book Series A: e-Books on Cardiovascular Diseases.

Volume Three: Etiologies of Cardiovascular Diseases – Epigenetics, Genetics and Genomics which is now available on Amazon Kindle at http://www.amazon.com/dp/B018PNHJ84.

This e-Book is a comprehensive review of recent Original Research on Cardiovascular Diseases: Causes, Risks and Management and related opportunities for Targeted Therapy written by Experts, Authors and Writers. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012.

This e-Book includes a thorough evaluation of a rich source of research literature on the genomic influences, which may have variable strength in the biological causation of atherosclerosis, microvascular disease, plaque formation, not necessarily having expressing, except in a multivariable context that includes the environment, dietary factors, level of emotional stress, sleep habits, and the daily activities of living for affected individuals. The potential of genomics is carried in the DNA, copied to RNA, and this is most well studied in the micro RNAs (miRNA). The miRNA has been explored for the appearance in the circulation of specific miRNAs that might be associated with myocyte or endothelial cell injury, and they are also being used as targets for therapeutics by the creation of silencing RNAs (siRNA). We invite e-Readers to write an Article Reviews on Amazon for this e-Book on Amazon.

All forthcoming BioMed e-Book Titles can be viewed at: http://pharmaceuticalintelligence.com/biomed-e-books/

Leaders in Pharmaceutical Business Intelligence, launched in April 2012 an Open Access Online Scientific Journal is a scientific, medical and business multi expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medicine industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceuticals & medicine. In addition the venture publishes a Medical E-book Series available on Amazon's Kindle platform.

Analyzing and sharing the vast and rapidly expanding volume of scientific knowledge has never been so crucial to innovation in the medical field. WE are addressing need of overcoming this scientific information overload by:

- Delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search in the near future

- Providing a social platform for scientists and clinicians to enter into discussion using social media

- Compiling recent discoveries and issues in yearly-updated Medical E-book Series on Amazon's mobile Kindle platform

This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series C: e-Books on Cancer & OncologyVolume One: Cancer Biology and Genomics for Disease Diagnosis

Newtown, MA -- (ReleaseWire) -- 08/17/2015 -- Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series C: e-Books on Cancer & Oncology

Volume One: Cancer Biology and Genomics for Disease Diagnosis

which is now available on Amazon Kindle at http://www.amazon.com/dp/B013RVYR2K. This e-Book is a comprehensive review of recent Original Research on Cancer & Genomics including related opportunities for Targeted Therapy written by Experts, Authors, Writers. This ebook highlights some of the recent trends and discoveries in cancer research and cancer treatment, with particular attention how new technological and informatics advancements have ushered in paradigm shifts in how we think about, diagnose, and treat cancer. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012. All new articles on this subject, will continue to be incorporated, as published with periodical updates.

We invite e-Readers to write an Article Reviews on Amazon for this e-Book on Amazon.

All forthcoming BioMed e-Book Titles can be viewed at:
http://pharmaceuticalintelligence.com/biomed-e-books/

Leaders in Pharmaceutical Business Intelligence, launched in April 2012 an Open Access Online Scientific Journal is a scientific, medical and business multi expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medicine industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceuticals & medicine. In addition the venture publishes a Medical E-book Series available on Amazon's Kindle platform.

Analyzing and sharing the vast and rapidly expanding volume of scientific knowledge has never been so crucial to innovation in the medical field. WE are addressing need of overcoming this scientific information overload by:

1. delivering curation and summary interpretations of latest findings and innovations on an
open-access, Web 2.0 platform with future goals of providing primarily concept-driven search
in the near future
2. providing a social platform for scientists and clinicians to enter into discussion using
social media
3. compiling recent discoveries and issues in yearly-updated Medical E-book Series on Amazon's
mobile Kindle platform

This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

LPBI announces the publication of their second curated medical E-book. This e-Book is a comprehensive review of recent Original Research on METABOLOMICS and related opportunities for Targeted Therapy written by Experts, Authors, Writers.

Newtown, MA -- (ReleaseWire) -- 08/12/2015 -- Leaders in Pharmaceutical Business Intelligence would like to announce the First volume of their BioMedical E-Book Series D:

Metabolic Genomics & Pharmaceutics, Vol. I

which is now available on Amazon Kindle at http://www.amazon.com/dp/B012BB0ZF0.

This e-Book is a comprehensive review of recent Original Research on METABOLOMICS and related opportunities for Targeted Therapy written by Experts, Authors, Writers. This is the first volume of the Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases. It is written for comprehension at the third year medical student level, or as a reference for licensing board exams, but it is also written for the education of a first time baccalaureate degree reader in the biological sciences. Hopefully, it can be read with great interest by the undergraduate student who is undecided in the choice of a career. The results of Original Research are gaining value added for the e-Reader by the Methodology of Curation. The e-Book's articles have been published on the Open Access Online Scientific Journal, since April 2012. All new articles on this subject, will continue to be incorporated, as published with periodical updates.

We invite e-Readers to write an Article Reviews on Amazon for this e-Book on Amazon.

All forthcoming BioMed e-Book Titles can be viewed at:
http://pharmaceuticalintelligence.com/biomed-e-books/

Leaders in Pharmaceutical Business Intelligence, launched in April 2012 an Open Access Online Scientific Journal is a scientific, medical and business multi expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medicine industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceuticals & medicine. In addition the venture publishes a Medical E-book Series available on Amazon's Kindle platform.

Analyzing and sharing the vast and rapidly expanding volume of scientific knowledge has never been so crucial to innovation in the medical field. WE are addressing need of overcoming this scientific information overload by:

1. delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search in the near future

2. providing a social platform for scientists and clinicians to enter into discussion using social media

3. compiling recent discoveries and issues in yearly-updated Medical E-book Series on Amazon's mobile Kindle platform

This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Newtown, MA -- (SBWIRE) -- 11/18/2014 -- Over 500,000 Unique Site Visits reached by pharmaceuticalintelligence.com Reported today by Leaders in Pharmaceutical Business Intelligence (LBPI)

Leaders in Pharmaceutical Business Intelligence (LBPI), launched in April 2012 as an Open Access Online Scientific Journal http://pharmaceuticalintelligence.com, has reached over 500,000 unique site visits, with approximately 30,000 monthly views, 1,440 followers and 133 sites linking into the journal, including ncbi.nlm.nih.gov, nature.com, cancer.gov, commons.wikipedia.org, dx.doi.org, NEJM (New England Journal of Medicine), medscape.com, personalizedmedicine.partners.org, masspec.scripps.edu, and sciencedirect.com.

Leaders in Pharmaceutical Business Intelligence is a scientific, medical and business multi-expert authoring platform in several domains, life sciences, pharmaceutical, healthcare & medical industries. The venture operates as an online scientific intellectual exchange at its website http://pharmaceuticalintelligence.com for curation and reporting on innovations in biomedical and biological sciences, healthcare economics, pharmacology, pharmaceutical research & medicine by PhD level Scientists, MDs, MD/PhDs and PharmDs. The Open Access Online Scientific Journal currently contains 2,521 annotated & curated articles in over 300 categories of research in Biotech, Life Sciences and Medicine.

The LPBI venture publishes a BioMedical Series of e-Books available on mobile platforms (current & future titles at http://pharmaceuticalintelligence.com/biomed-e-books/

In the Funding, Deals and Partnerships, the venture represents more than a dozen of early stage Biotechnology and Medical Devices startups in Private Equity Funding.

The venture's expertise in Real-Time Scientific Conferences Coverage, using social media and creating electronic scientific conference proceedings posted on the Internet, has included the following events: MassBio Annual Meeting 2014, BioIT World, April 30, 2014, Koch Institute for Integrative Cancer Research @MIT – Summer Symposium 2014: RNA Biology, Cancer and Therapeutic Implications, June 13, 2014, Gabbay Award Lectures in Biotechnology and Medicine – Hosted by Rosenstiel Basic Medical Sciences Research Center, Brandeis University, October 27, 2014, 10th Annual Personalized Medicine Conference at the Harvard Medical School, November 12-13, 2014, and two Biotech Investment Conferences in 2014, one in NYC and one in Basel by Sachs Associates of London.

Contact:
Aviva Lev-Ari, PhD, RN
617-244-4024
avivalev-ari@alum.berkeley.edu
Scientific Journal and BioMed e-Books Series - Editor-in-Chief
http://pharmaceuticalintelligence.com/biomed-e-books/
Founder & Director
Leaders in Pharmaceutical Business Intelligence
http://pharmaceuticalintelligence.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Newtown, MA -- (SBWIRE) -- 07/18/2013 -- Leaders in Pharmaceutical Business Intelligence, launched in April 2012 as an Open Access Online Scientific Journal (http://pharmaceuticalintelligence.com), would like to announce the FIRST book of their BioMedical E-Book Series, Perspectives on Nitric Oxide in Disease Mechanisms, which is now available on Amazon Kindle (http://www.amazon.com/dp/B00DINFFYC). This book is a comprehensive review of Nitric Oxide, its discovery, function, and related opportunities for targeted therapy written by PhDs, MDs, MD/PhDs, PharmDs.

Leaders in Pharmaceutical Business Intelligence is a scientific, medical and business multi-expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medical industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceutical & medicine. In addition the venture publishes a BioMedical E-book Series available on Amazon's Kindle platform (future titles at http://pharmaceuticalintelligence.com/biomed-e-books/).

Analyzing and sharing the vast amounts of scientific knowledge has never been so crucial to innovation in the medical field. The publication rate has steadily increased from the 70's, with a 50% increase in the number of original research articles published from the 1990's to the previous decade. This massive amount of biomedical and scientific information has presented the unique problem of an information overload, and the critical need for methodology and expertise to organize, curate, and disseminate this diverse information for scientists and clinicians. Dr. Larry Berstein, President of Triplex Consulting and previously chief of pathology at New York's Methodist Hospital, concurs that "the academic pressures to publish, and the breakdown of knowledge into "silos", has contributed to this knowledge explosion and although the literature is now online and edited, much of this information is out of reach to the very brightest clinicians."

Traditionally, organization of biomedical information has been the realm of the literature review, but most reviews are performed years after discoveries are made and, given the rapid pace of new discoveries, this is appearing to be an outdated model. In addition, most medical searches are dependent on keywords, hence adding more complexity to the investigator in finding the material they require. Third, medical researchers and professionals are recognizing the need to converse with each other, in real-time, on the impact new discoveries may have on their research and clinical practice.

These issues require a people-based strategy, having expertise in a diverse and cross-integrative number of medical topics to provide the in-depth understanding of the current research and challenges in each field as well as providing a more conceptual-based search platform. To address this need, human intermediaries, known as scientific curators, are needed to narrow down the information and provide critical context and analysis of medical and scientific information in an interactive manner powered by web 2.0 with curators referred to as the "researcher 2.0". This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

We are addressing the need to organize the massive amount of scientific information by:

- Delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search

- Providing a social platform for scientists and clinicians to enter into discussion using social media

- Compiling recent discoveries and issues in yearly-updated BioMedical E-book Series on Amazon's mobile Kindle platform.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm